Prescribing Statins to People with Heart Disease 2022-23 Edition

When comparing plans, small differences between scores are expected. The larger differences are important.

Prescribing Statins to People with Heart Disease

  • (Worse)
    0%
  • (Better)
    100%
Kaiser Permanente - Northern California - HMO 89% Horizontal bar, 89 units
Kaiser Permanente - Southern California - HMO 89% Horizontal bar, 89 units
Aetna Health of California, Inc. - HMO 87% Horizontal bar, 87 units
Sharp Health Plan - HMO 84% Horizontal bar, 84 units
Aetna - PPO 83% Horizontal bar, 83 units
Blue Shield of California - HMO 83% Horizontal bar, 83 units
Anthem Blue Cross - HMO 82% Horizontal bar, 82 units
CIGNA - HMO 82% Horizontal bar, 82 units
CIGNA - PPO 82% Horizontal bar, 82 units
Health Net of California, Inc. - HMO 82% Horizontal bar, 82 units
UnitedHealthcare Insurance Co., Inc. - PPO 82% Horizontal bar, 82 units
UnitedHealthcare of California - HMO 82% Horizontal bar, 82 units
Anthem Blue Cross - PPO 81% Horizontal bar, 81 units
Western Health Advantage - HMO 81% Horizontal bar, 81 units
Blue Shield of California/Blue Shield Life - PPO 80% Horizontal bar, 80 units
Health Net Life Insurance Company - PPO 78% Horizontal bar, 78 units

Data Disclaimer  
The source for data contained in this publication is Quality Compass®2022 and is used with the permission of the National Committee for Quality Assurance (NCQA). Quality Compass® 2022 includes certain Consumer Assessment of Healthcare Providers and Systems (CAHPS®) data. Any data display, analysis, interpretation, or conclusion based on these data is solely that of the authors, and NCQA specifically disclaims responsibility for any such display, analysis, interpretation, or conclusion. Quality Compass is a registered trademark of NCQA. CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).

Users of the data shall not have the right to alter, enhance, or otherwise modify the data. Anyone desiring to use or reproduce the data without modification for a noncommercial purpose may do so without obtaining any approval from NCQA. All commercial uses must be approved by NCQA and are subject to a license at the discretion of NCQA. Use by health care providers in connection with their own practices is not commercial use. A "commercial use" refers to any sale, license, or distribution of the data for commercial gain, or incorporation of the data into any product or service that is sold, licensed, or distributed for commercial gain, even if there is no actual charge for inclusion of the data. ©2004-2022 National Committee for Quality Assurance, all rights reserved.

311.110/311.210